FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ivana Gojo

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
L A Tobin; Alan E Tomkinson; C Robert; Maria R Baer; Ivana Gojo; Aaron P Rapoport; Feyruz V Rassool
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
Ivana Gojo; Rena Lapidus; Mariola Sadowska; Rakesh K Srivastava; Ming Tan; Bean N Anyang; Maria R Baer; Jan H Beumer; France Carrier; Igor Espinoza-Delgado; Hongbin Fang; Douglas D Ross
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia.
Kelly Norsworthy; Leo Luznik; Ivana Gojo
New treatment approaches in acute myeloid leukemia: review of recent clinical studies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ivana Gojo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: L A Tobin; Alan E Tomkinson; C Robert; Maria R Baer; Ivana Gojo; Aaron P Rapoport; Feyruz V Rassool
Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
Oncogene 2013;32(14):1784-93.
2013: Ivana Gojo; Rena Lapidus; Mariola Sadowska; Rakesh K Srivastava; Ming Tan; Bean N Anyang; Maria R Baer; Jan H Beumer; France Carrier; Igor Espinoza-Delgado; Hongbin Fang; Douglas D Ross
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(7):1838-51.
2012: Kelly Norsworthy; Leo Luznik; Ivana Gojo
New treatment approaches in acute myeloid leukemia: review of recent clinical studies.
Reviews on recent clinical trials 2012;7(3):224-37.
2012: S N Singh; Q Cao; Ivana Gojo; Aaron P Rapoport; Gorgun Akpek
Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT.
Bone marrow transplantation 2012;47(7):1008-9.
2012: J Yared; Ivana Gojo; Gorgun Akpek
Glans penis involvement: an under-recognized manifestation of chronic GVHD.
Bone marrow transplantation 2012;47(7):1006-7.
2012: Michael W Evans; Ivana Gojo; Jacqueline Greer; Judith E Karp; Mark Levis; Anthony D Sung; Michael L Tidwell; Maria R Baer
Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia.
Leukemia & lymphoma 2012;53(4):660-4.
2012: Jason Bierenbaum; Michael L Tidwell; Ivana Gojo; Amy J Davidoff; Yi Ning; Maria R Baer
Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience.
Leukemia research 2012;36(2):140-5.
2012: Seble S Chekol; Ivana Gojo; Bhavana Bhatnagar; John R Hess
Leukopheresis for profound hyperleukocytosis.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2012;46(1):29-31.
2011: Jenna Vanliere Canzoniero; Maria R Baer; Bhavana Bhatnagar; Ivana Gojo
Upfront therapy of acute myeloid leukemia.
Current oncology reports 2011;13(5):361-70.
2011: Gorgun Akpek; Y T Akpolat; Ivana Gojo; T Huebner; Olga B Ioffe; Michael E Kleinberg; Aaron P Rapoport; A Taner; A Uslu; Maria R Baer
Granulomatous amebic encephalitis: an under-recognized cause of infectious mortality after hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2011;13(4):366-73.
2011: Shiven B Patel; Edward A Sausville; Michael L Tidwell; Ivana Gojo; Maria R Baer
Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy.
Leukemia & lymphoma 2011;52(7):1211-4.
2011: Maria R Baer; Ivana Gojo
Novel agents for the treatment of acute myeloid leukemia in the older patient.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(3):331-5.
2011: L Yu; J C Reader; C Chen; Xianfeng Frank Zhao; J S Ha; C Lee; Teresa A York; Ivana Gojo; Maria R Baer; Yi Ning
Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia.
Leukemia 2011;25(2):367-71.
2010: J E Lancet; Ivana Gojo; M Burton; M Quinn; S M Tighe; K Kersey; Z Zhong; M X Albitar; Kapil N Bhalla; A L Hannah; Maria R Baer
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia.
Leukemia 2010;24(4):699-705.
2010: Steven D Gore; Ivana Gojo; Mikkael A Sekeres; Lawrence Morris; Marcel Devetten; Katarzyna Jamieson; Robert L Redner; Robert J Arceci; Ibitayo Owoeye; Tianna Dauses; Esther Schachter-Tokarz; Robert E Gallagher
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(6):1047-53.
2009: Ken Shiozawa; Takeo Nakanishi; Ming Tan; Hongbin Fang; Wen-chyi Wang; Martin J Edelman; David Carlton; Ivana Gojo; Edward A Sausville; Douglas Ross
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(5):1698-707.
2009: Xianfeng Frank Zhao; Ivana Gojo; Teresa A York; Yi Ning; Maria R Baer
Diagnosis of biphenotypic acute leukemia: a paradigmatic approach.
International journal of clinical and experimental pathology 2009;3(1):75-86.
2008: GF Kao; Brooke Resh; Christine McMahon; Ivana Gojo; Chen-Chih Sun; Daniel Phillips; Xianfeng Frank Zhao
Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature.
The American Journal of dermatopathology 2008;30(6):593-9.
2008: Ivana Gojo
Improving treatment strategies for acute lymphoblastic leukemia by combining immunotherapy and chemotherapy.
Leukemia research 2008;32(6):847-9.
2008: Judith E Karp; B Douglas Smith; Ivana Gojo; Jeffrey E Lancet; Jacqueline Greer; Maureen Klein; Larry Morris; Mark Levis; Steven D Gore; John J Wright; Elizabeth Garrett-Mayer
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(10):3077-82.
2008: mitch raponi; Jeffrey E Lancet; Hongtao Fan; Lesley Dossey; Grace Lee; Ivana Gojo; Eric J Feldman; Jason Gotlib; Lawrence E Morris; Peter L Greenberg; John J Wright; Jean-Luc Harousseau; Bob Löwenberg; Richard M Stone; Peter De Porre; Yixin Wang; Judith E Karp
A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia.
Blood 2008;111(5):2589-96.
2008: Judith E Karp; Francis Giles; Ivana Gojo; Lawrence Morris; Jacqueline Greer; Bonny Johnson; Mya Thein; Mario Sznol; Jennifer Low
A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders.
Leukemia research 2008;32(1):71-7.
2007: Ivana Gojo; Michael L Tidwell; Jacqueline Greer; Naoko Takebe; Karen Seiter; Mary F Pochron; Bonny Johnson; Mario Sznol; Judith E Karp
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies.
Leukemia research 2007;31(9):1165-73.
2007: J C Reader; J S Meekins; Ivana Gojo; Yi Ning
A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia.
Leukemia 2007;21(4):842-4.
2007: Ivana Gojo; Anchalee Jiemjit; Jane Trepel; Alex Sparreboom; William D Figg; Sandra Rollins; Michael L Tidwell; Jacqueline Greer; Eun Joo Chung; Min-Jung Lee; Steven D Gore; Edward A Sausville; James Zwiebel; Judith E Karp
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias.
Blood 2007;109(7):2781-90.
2007: Jeffrey E Lancet; Ivana Gojo; Jason Gotlib; Eric J Feldman; Jacqueline Greer; Jane L Liesveld; Laura M Bruzek; Lawrence Morris; Youn Park; Alex A. Adjei; Scott H Kaufmann; Elizabeth Garrett-Mayer; Peter L Greenberg; John J Wright; Judith E Karp
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.
Blood 2007;109(4):1387-94.
2007: Borislav Alexiev; Wenle Wang; Yi Ning; Saranya Chumsri; Ivana Gojo; William H Rodgers; Sanford A Stass; Xianfeng Frank Zhao
Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study.
Diagnostic pathology 2007;2():42.
2006: Milin R Acharya; Judith E Karp; Edward A Sausville; Kyunghwa Hwang; Qin C Ryan; Ivana Gojo; Jürgen Venitz; William D Figg; Alex Sparreboom
Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer.
Investigational new drugs 2006;24(5):367-75.
2006: Ivana Gojo; Barry Meisenberg; C Guo; AB Fassas; A Murthy; Robert G Fenton; Naoko Takebe; Meyer Heyman; G L Philips; Michele Cottler-Fox; Clarence Sarkodee-Adoo; Kathy Ruehle; T French; Ming Tan; Guido Tricot; Aaron P Rapoport
Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma.
Bone marrow transplantation 2006;37(1):65-72.
2005: Judith E Karp; Antonino Passaniti; Ivana Gojo; Scott Kaufmann; Keith C Bible; Tushar S Garimella; Jacqueline Greer; Janet Briel; B Douglas Smith; Steven D Gore; Michael L Tidwell; Douglas Ross; John J Wright; A Dimitrios Colevas; Kenneth S. Bauer
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8403-12.
2005: Scott H Kaufmann; Judith E Karp; Louis Letendre; Timothy J Kottke; Stephanie L Safgren; Jacqueline Greer; Ivana Gojo; Pamela J Atherton; Phyllis A Svingen; David Loegering; Mark R Litzow; Jeff A Sloan; Joel M Reid; Matthew M Ames; Alex A. Adjei; Charles Erlichman
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6641-9.
2005: Mohan K Tummala; Leno Thomas; Christopher D Gocke; Meyer R Heyman; Ivana Gojo
Unusual leukemia presentations. Case 2. Granulocytic sarcoma of the colon.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5840-1.
2005: Steven D Gore; B Douglas Smith; Ivana Gojo; Michael R Grever; Scott H Kaufmann; Louis Letendre; Debra G B Leonard; Guido Marcucci; Carole B Miller; Lawrence Morris; Steven Piantadosi; Thomas Prior; Wendy Stock; Judith E Karp
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia.
American journal of hematology 2005;79(2):119-27.
2005: Eun Joo Chung; Sunmin Lee; Edward A Sausville; Qin C Ryan; Judith E Karp; Ivana Gojo; William G Telford; Min-Jung Lee; Hye Sik Kong; Jane Trepel
Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometry.
Annals of clinical and laboratory science 2005;35(4):397-406.
2004: Aaron P Rapoport; C Guo; Ashraf Badros; Roger Hakimian; Gorgun Akpek; E Kiggundu; Barry Meisenberg; Heather D Mannuel; Naoko Takebe; Robert G Fenton; F. JAVIER BOLANOS MEADE; Meyer Heyman; Ivana Gojo; Kathy Ruehle; S Natt; Bashi Ratterree; T Withers; Clarence Sarkodee-Adoo; Gordon L Phillips; Guido Tricot
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;34(10):883-90.
2004: Leno Thomas; Judith Stamberg; Ivana Gojo; Yi Ning; Aaron P Rapoport
Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature.
American journal of hematology 2004;77(1):55-61.
2004: Ivana Gojo; C Guo; Clarence Sarkodee-Adoo; Barry Meisenberg; AB Fassas; Aaron P Rapoport; Michele Cottler-Fox; Meyer Heyman; Naoko Takebe; Guido Tricot
High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity.
Bone marrow transplantation 2004;34(1):69-76.
2004: Judith E Karp; Ivana Gojo; Roberto Pili; Christopher D Gocke; Jacqueline Greer; Chuanfa Guo; Zheng (David) Qian; Lawrence Morris; Michael L Tidwell; Helen Chen; James Zwiebel
Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3577-85.
2004: F. JAVIER BOLANOS MEADE; Chuanfa Guo; Ivana Gojo; Judith E Karp
A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML.
Leukemia research 2004;28(6):571-7.
2002: Ivana Gojo; Bin Zhang; Robert G Fenton
The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3527-38.
2002: Bin Zhang; Ivana Gojo; Robert G Fenton
Myeloid cell factor-1 is a critical survival factor for multiple myeloma.
Blood 2002;99(6):1885-93.
2001: AB Fassas; Ivana Gojo; Aaron P Rapoport; Michele Cottler-Fox; Barry Meisenberg; John C Papadimitriou; Guido Tricot
Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy.
Bone marrow transplantation 2001;28(4):399-403.
2001: Judith E Karp; Jeffrey E Lancet; Scott H Kaufmann; David W End; John J Wright; K Bol; I Horak; Michael L Tidwell; Jane L Liesveld; Timothy J Kottke; D Ange; Laxmi N Buddharaju; Ivana Gojo; W Edward Highsmith; Robert T Belly; R J Hohl; M E Rybak; A Thibault; Joseph D Rosenblatt
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.
Blood 2001;97(11):3361-9.
2001: Ivana Gojo; Judith E Karp
The impact of biology on the treatment of secondary AML.
Cancer treatment and research 2001;108():231-55.
2000: Ivana Gojo; Katherine Tkaczuk
A phase I study of paclitaxel, UFT, and leucovorin.
Oncology (Williston Park, N.Y.) 2000;14(10 Suppl 9):76-8.
1999: Clarence Sarkodee-Adoo; Ivana Gojo; Meyer R Heyman
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
The New England journal of medicine 1999;340(17):1368; author reply 1369.